ConMed proxy war gets ugly
February 28, 2014 by Brad Perriello
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
ConMed earlier this week struck a deal with Coppersmith Capital Management that unseated ConMed founder Eugene Corasanti’s chairmanship and added Coppersmith managing partner Jerome Lande and former Stryker (NYSE:SYK) CFO Curtis Hartman as directors effective March 1. Read more
Madaus is new CEO at Carlyle's Ortho-Clinical Diagnostics
February 27, 2014 by Chris Walker
The Carlyle Group said it tapped Martin Madaus to take over as CEO of the Ortho-Clinical Diagnostics business it’s acquiring from Johnson & Johnson.
Carlyle snaked the business away from several other PE groups who submitted 1st-round bids in September 2013, including Blackstone Group, Kohlberg Kravis Roberts, Bain Capital and BC Partners. Read more
Masimo alleges conflict of interest in arbitration award
March 4, 2014 by Brad Perriello
Masimo accused the arbitrator who handed it a $5.4 million loss in a wrongful termination lawsuit brought by 2 former sales reps of hiding a major conflict of interest and of misapplying the law in his ruling.
The ex-reps, Michael Ruhe and Vicente Catala, accused Masimo of promoting off-label uses for its Pronto and Pronto-7 patient monitoring devices, improperly billing government insurance programs, withholding sales records and interfering with subpoenas. Read more
Medtronic vet takes over marketing at Vexim | Personnel Moves
March 5, 2014 by Arezu Sarvestani
French spinal devices maker Vexim this month welcome Medtronic veteran Sandrine Carle as its director of marketing.
Carle spent 15 years at Medtronic, focusing in particular on the medtech titan’s spinal business, Vexim said. She began in Medtronic’s French spinal business but later oversaw operations abroad. Read more
Health quality president Cassel reluctantly ditches board seats amid conflict scandal
March 6, 2014 by Arezu Sarvestani
National Quality Forum president & CEO Dr. Christine Cassel voluntarily resigned her seat on the boards of a couple of high-profile healthcare industry groups as questions continue to swirl about potential conflicts of interest among the Forum’s leaders.
Cassel stepped down from the boards of health giant Kaiser Permanente and group purchasing organization Premier Inc., NQF revealed. Cassel lamented her departure from those companies, saying that her involvement was important but that ongoing inquiries were getting in the way of her work at NQF. Read more
